Related Experiment Video

Updated: Aug 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Activated Ras enhances insulin-like growth factor I induction of vascular endothelial growth factor in prostate

Mark Stearns1, Jordan Tran, Mary Kay Francis

  • 1Department of Pathology, Drexel University School of Medicine, Philadelphia, Pennsylvania, USA.

Cancer Research
|March 23, 2005
PubMed

Insights

RAS gene mutations in cancer increase vascular endothelial growth factor (VEGF) production. Activated HRAS in prostate cells stimulates VEGF release in response to insulin-like growth factor I (IGF-I).

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • RAS gene mutations (HRAS, KRAS, NRAS) are prevalent in human cancers, affecting up to 50% in some types.
  • Activated Ras proteins can elevate vascular endothelial growth factor (VEGF) production, leading to increased tumor vascularity.
  • Insulin-like growth factor I (IGF-I) is linked to increased cancer risk.

Purpose of the Study:

  • To investigate the relationship between activated HRAS and VEGF production in response to IGF-I.
  • To explore the signaling pathways involved in Ras-mediated VEGF regulation.

Main Methods:

  • Prostate epithelial cells were utilized to study the effects of activated HRAS.
  • Cells were treated with IGF-I to assess VEGF production.
  • Investigated the role of insulin receptor substrate 1 and PI 3-kinase signaling.

Main Results:

  • Introduction of activated HRAS into prostate cells induced VEGF production in response to IGF-I.
  • Cells without activated Ras did not produce VEGF when stimulated by IGF-I.
  • Ras may stabilize insulin receptor substrate 1, mediating PI 3-kinase-dependent signaling.

Conclusions:

  • Oncogenic HRAS activation creates a novel link with IGF-I signaling in prostate epithelial cells.
  • This interaction promotes VEGF production, potentially contributing to cancer progression and vascularization.
  • Findings suggest a mechanism connecting cellular oncogene activation with hormonal signaling in cancer development.

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...